Trial Information

Summary: Prostate Negative Biopsy Trial

This clinical trial will test whether the trace element selenium will help men who have received a negative biopsy for prostate cancer within the last year.

Participants must be less than 80 years old, have a PSA above 4ng/ml, a rising PSA or have had an abnormal digital rectal exam, have no prior history of cancer (except skin cancer) in the past five years, have never undergone chemotherapy or radiation treatment, and may not be taking more than 50 mcg of selenium.

If you would like to learn more about participating in this study, please send an e-mail message using the form below.